Findings underscore importance of efforts to bolster mental resilience, say researchers The ability to cope well with, and adapt to, challenging life circumstances and events ...
But randomised controlled trials are needed to confirm these findings Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater ...
High dose psilocybin was the only psychedelic treatment to reduce depressive symptoms by more than placebo in antidepressant trials High doses of psilocybin - the ...
Results highlight ongoing need for research and prevention efforts among doctors, particularly women Suicide rates among doctors have declined over time, but are still significantly ...
Associations held after factoring in diabetes and limiting age of first stroke up to 40 Assessments beyond traditional stroke risk factors now needed, suggest researchers ...
Nearly 1 in 4 say gambling has affected their personal/professional lives over past year Better, earlier, and targeted support needed, urge researchers Several indicative factors, ...
The BMJ Press Notice: 4 May 2024 Expression of concern placed on research paper: Efficacy of psilocybin for treating symptoms of depression It has come ...
Risks highest soon after starting drugs, underscoring need for increased caution in early stages of treatment, say experts Antipsychotic use in people with dementia is ...
Sweet spot seems to be 0.68 mg/day among healthy older people to ward off decline Optimal maintenance dose seems to be 0.6 to less than ...
Women’s health cannot be allowed to be hijacked by vested interests, say experts Feminist health narratives are being co-opted by commercial interests to market new ...
